AF
COGT icon

Allworth Financial’s Cogent Biosciences COGT Stock Holding History

Allworth Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8K Buy
590
+270
+84% +$9.45K ﹤0.01% 3086
2026
Q1 		$12.3K Buy
320
+292
+1,043% +$10.8K ﹤0.01% 3366
2025
Q4 		$995 Buy
28
+24
+600% +$675 ﹤0.01% 4355
2025
Q3 		$58 Buy
+4
New +$47 ﹤0.01% 4733
2025
Q1 		– Sell
-33
Closed -$271 – 4082
2024
Q4 		$271 Sell
33
-27
-45% -$269 ﹤0.01% 3732
2024
Q3 		$648 Hold
60
– – ﹤0.01% 3359
2024
Q2 		$517 Buy
60
+27
+82% +$205 ﹤0.01% 3363
2024
Q1 		$222 Buy
+33
New +$204 ﹤0.01% 3436
2023
Q4 		– Sell
-12
Closed -$117 – 3490
2023
Q3 		$117 Buy
+12
New +$142 ﹤0.01% 3321

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allworth Financial's COGT Position: Q2 2026 in Review

Allworth Financial increased its Cogent Biosciences (COGT) stake by 84% in Q2 2026, buying an estimated $9.45K and bringing the position to 590 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

Allworth Financial first reported a position in COGT in Q3 2023 and has held it in 9 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Allworth Financial held 590 shares of Cogent Biosciences worth $22.8K as of Q2 2026.
  • Allworth Financial bought 270 Cogent Biosciences shares in Q2 2026, an estimated $9.45K.
  • Cogent Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3086 holding.
  • Allworth Financial first reported a position in Cogent Biosciences in Q3 2023 and has held it in 9 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.